Treatment research progress of primary immune thrombocytopenia / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 253-256, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-753578
ABSTRACT
Primary immune thrombocytopenia is an autoimmune disease characterized by reduced platelets, accompanied by or without skin mucous bruises,epistaxis,internal bleeding,etc.Recent years,the treatment of primary immune thrombocytopenia developed very quickly, including the appearance of platelet receptor agonist - Eltrom-bopag.Here,we reviewed the treatment and research development of primary immune thrombocytopenia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS